Nutritional support of the patient receiving high-dose therapy with hematopoietic stem cell support
نویسندگان
چکیده
منابع مشابه
Nutritional support of the patient receiving high-dose therapy with hematopoietic stem cell support.
Hematopoietic stem cell transplantation (HSCT) is an intensive therapy that is being used increasingly in an attempt to cure certain malignancies. One of the major adverse effects of this treatment is an inadequate oral intake that may result in dehydration and malnutrition. Factors that may contribute to inadequate oral intake include mucositis, nausea, vomiting, and anorexia. In addition, pri...
متن کاملOral Ciprofloxacin Prophylaxis in Patients Undergoing High Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation
Background: Antibiotic prophylaxis is usually used in allogenic stem cell transplantation, but its use in Autologous Stem Cell Transplantation (ASCT) is controversial. We evaluated the efficacy of ciprofloxacin prophylaxis in ASCT. Materials and Methods: To identify the efficacy of ciprofloxacin on the incidence of neutropenic fever and its complications, 72 patients had been admitted to Talegh...
متن کاملOral Ciprofloxacin Prophylaxis in Patients Undergoing High Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation
Background: Antibiotic prophylaxis is usually used in allogenic stem cell transplantation, but its use in Autologous Stem Cell Transplantation (ASCT) is controversial. We evaluated the efficacy of ciprofloxacin prophylaxis in ASCT. Materials and Methods: To identify the efficacy of ciprofloxacin on the incidence of neutropenic fever and its complications, 72 patients had been admitted to Talegh...
متن کاملHigh-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.
BACKGROUND High-dose therapy with autologous stem cell support (HDT) has been a treatment option for lymphomas in Norway for 25 years. The purpose of the article was to describe the use of the therapy for lymphomas for the country as a whole and by health region, and to reveal the overall survival rate. METHOD All lymphoma patients ≥ 18 years who received HDT in Norway in the period 1987-2008...
متن کاملHigh-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment.
High-dose therapy with autologous stem cell support (HDT) has been a therapeutic option for lymphomas in Norway since as far back as 1987. By restoring bone marrow function through reinfusion of the patient's own stem cells, it is possible to administer cancer treatment in higher and otherwise lethal doses, and thereby achieve better treatment results. Originally stem cells were harvested from ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Oncology Nursing Journal
سال: 2002
ISSN: 1181-912X
DOI: 10.5737/1181912x122102107